Sign in

CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Climb Bio, Inc.

Sign in to watch
Ticker
CLYM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
832273741
Phone
1-866-857-2596
Business address
20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
Former names
Eliem Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Option exercise Director acquired 25,093 shares (option exercise)
  5. 4 Planned sale SVP, Finance & CAO sold 1,199 shares at $1.31 ($1,571)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Option exercise Director acquired 50,188 shares (option exercise)
  10. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 1,235 shares at $2.02 ($2,495)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 1,191 shares at an average $8.18 ($9,741)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale EVP, R&D AND CSO sold 129,206 shares at an average $7.65 ($988,495)
  17. 4 Open-market sale EVP, R&D AND CSO sold 41,783 shares at an average $6.93 ($289,492)
  18. 4 Open-market sale EVP, R&D AND CSO sold 50,000 shares at $7.13 ($356,500)
  19. 4 Open-market sale EVP, R&D AND CSO sold 92,377 shares at an average $7.04 ($650,563)
  20. 4 Open-market sale EVP, R&D AND CSO sold 105,931 shares at an average $6.95 ($736,500)

Page 3 of 6 · 119 filings